...
首页> 外文期刊>Blood purification >Cytokine Adsorptive Property of Various Adsorbents in Immunoadsorption Columns and a Newly Developed Adsorbent: An in vitro Study.
【24h】

Cytokine Adsorptive Property of Various Adsorbents in Immunoadsorption Columns and a Newly Developed Adsorbent: An in vitro Study.

机译:免疫吸附柱中各种吸附剂和新开发的吸附剂对细胞因子的吸附性能:体外研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Cytokines play important roles in the pathophysiology of systemic inflammatory response syndrome (SIRS) and sepsis. Therefore, some effective measures to remove cytokines from the bloodstream could be effective in the treatment of SIRS and sepsis. The aim of this study was to evaluate the cytokine adsorptive property of various adsorbents for the purpose of the development of new selective cytokine adsorption columns. Methods: The cytokine adsorptive property of adsorbent in a CF-X column, which consists of cellulose beads cross-linked with hexamethylene-di-isocyanate, was compared with those of various adsorbents in currently available immunoadsorption columns, such as Immusorba TR((R)), Immusorba PH((R)), Selesorb((R)), and Lixelle((R)), in vitro batchwise test using patients' plasma. A newly developed adsorbent, MPCF-X, which was modified by coating the surface of the adsorbent in CF-X with 2-methacryloyloxyethyl phosphorylcholine (MPC), was also tested for its cytokine adsorptive property. Results: The adsorbent in CF-Xshowed a significantly higher adsorption rate for TNF-alpha, interleukin (IL)-6 and IL-10 compared with other adsorbents (p < 0.05). Adsorbent in Lixelle((R)) showed good affinity to TNF-alpha and IL-8. Especially, the adsorbent in CF-X almost completely removed TNF-alpha, whereas it also had considerable affinity to normal IgG. MPCF-X showed decreased affinity to IgG with considerable adsorptive properties to cytokines. Conclusion: Selective cytokine adsorption columns could be developed with improvement of currently available adsorbents. Such a new selective cytokine adsorption column could be clinically applied for the treatment of SIRS/sepsis. Copyright (c) 2004 S. Karger AG, Basel.
机译:背景/目的:细胞因子在全身性炎症反应综合征(SIRS)和败血症的病理生理中起重要作用。因此,从血流中去除细胞因子的一些有效措施可能对SIRS和败血症的治疗有效。这项研究的目的是评估各种吸附剂对细胞因子的吸附性能,以开发新的选择性细胞因子吸附柱。方法:将CF-X色谱柱(由与六亚甲基二异氰酸酯交联的纤维素珠子组成)的吸附剂对细胞因子的吸附性能与目前可用的免疫吸附柱(如Immusorba TR(R)进行比较。 )),Immusorba PH(R),Selesorb(R)和Lixelle(R),使用患者血浆进行体外分批测试。还测试了新开发的吸附剂MPCF-X,该吸附剂通过在CF-X中的吸附剂表面涂上2-甲基丙烯酰氧基乙基磷酰胆碱(MPC)进行了修饰,并测试了其对细胞因子的吸附性能。结果:与其他吸附剂相比,CF-X中的吸附剂对TNF-α,白介素(IL)-6和IL-10的吸附率高得多(p <0.05)。 Lixelle中的吸附剂显示出对TNF-α和IL-8的良好亲和力。特别是,CF-X中的吸附剂几乎完全去除了TNF-α,而对正常IgG也具有相当大的亲和力。 MPCF-X对IgG的亲和力下降,对细胞因子具有明显的吸附特性。结论:可以通过改进现有的吸附剂开发选择性的细胞因子吸附柱。这种新型的选择性细胞因子吸附柱可在临床上用于SIRS /败血症的治疗。版权所有(c)2004 S.Karger AG,巴塞尔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号